Anavex Life Sciences Announces Plans To Refresh Board To Continue Overseeing Critical Progress And Stockholder Value Creation

Aug. 3 (Reuters) - Anavex Life Sciences Corp. AVXL.O:

• Anavex Life Sciences announces plans to refresh its board to continue overseeing critical progress and stockholder value creation.
• The company nominates Gautam Patel and Adrian Senderowicz as independent directors.
• Anavex Life Sciences urges stockholders to reject PVG Asset Management and Patrick S. Adams’ control attempt.
• Christopher Missling and Steffen Thomas are set to leave the board after the 2026 annual meeting.
• The company filed a preliminary proxy statement with the SEC on July 31, 2026.

Source text: ID:nGNX9Q9l2r